- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00230555
The MOM Program at the Children's Hospital of Philadelphia
September 29, 2005 updated by: Children's Hospital of Philadelphia
The purpose of the MOM Program is to promote child development by helping families become more competent in accessing and using available resources.
The program focuses are childhood immunizations, Early Intervention services, lead screening, Early Head Start and Head Start enrollment.
The hypothsis is that children receiving the intervention will participate in more of the public services and primary healthcare activities which have been shown to be effective in improving their development.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The MOM Program is a 3 year randomized controlled trial of mothers and newborns.
At enrollment subjects are given a questionnaire to assess self efficacy and a non-verbal test of intelligence.
Program personnel are blind to the results of this testing.
Test results will be used in data analysis at the end of the study to compare outcomes of the intervention and control groups and to assess how mothers with impaired cognitive ability have benefited from participation in the study.The Intervention consists of frequent phone calls and home visits to encourage mothers to have their babies immunized on schedule and to participate in needed developmental and educational services.
At 33 months of age all children receive a developmental assessment.
Study Type
Interventional
Enrollment
300
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 3 days (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria: mothers from West and South Philadelphia who have given birth on the post-partum unit at the Hospital of the University of Pennsylvania during the six month enrollment period from July, 2001 to Jan, 2002..
-
Exclusion Criteria: women or infants who are critically ill, those involving multiple births (ie twins), and women who are solely non-English speaking.
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
child intelligence, 33 months of age
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
At child age 33 months: maternal intelligence
|
|
At child age 33 months:caregiver depression
|
|
At child age 33 months: childhood immunization completion At child age 33 months: Early Intervention usage
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Donald F Schwarz, M.D., Children's Hospital of Philadelphia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2001
Study Completion
November 1, 2004
Study Registration Dates
First Submitted
September 29, 2005
First Submitted That Met QC Criteria
September 29, 2005
First Posted (Estimate)
October 3, 2005
Study Record Updates
Last Update Posted (Estimate)
October 3, 2005
Last Update Submitted That Met QC Criteria
September 29, 2005
Last Verified
April 1, 2005
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2001-4-2388
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.